Christoph Ruedig

PeakData helps pharmaceutical companies learn more about their customers through our agile targeting and segmentation SaaS platform. PeakData is used by more than half of the top 20 Pharmaceuticals and engages 50+ staff in our offices in the USA, Germany, UK, Poland, Netherlands, and Switzerland.

Launched in the US in 2023, NuvoAir is a purpose-built, integrated specialty care platform that is reinventing the operating model through which care to complex cardiopulmonary patients is delivered. We emphasize the management of exacerbations, the key contributors to high healthcare costs and longitudinal care. Our platform empowers physicians, helping them maintain autonomy, deliver outstanding care and enhance their revenue in ways previously unattainable. By collaborating with health plans, risk-bearing entities, and innovative cardiologists and pulmonologists, we have redefined how patients with complex heart and lung issues, receive high quality care. To discover more about how NuvoAir is advancing high-value care in the cardiopulmonary space and to explore NuvoAirs extensive body of clinical evidence, visit nuvoair.com. Our recruiting email is talent@nuvoair.com, do not hesitate to reach out for any open position. Erin Murphree will be reaching out to you within short notice!

uMed combines RWE with the power of patient generated data to address the evidence gaps in life science research. By leveraging uMed’s ACCESS Research Platform which is embedded across a global network of healthcare institutions, researchers can rapidly access and engage with patients to generate insights derived from the decentralised collection of electronic health records, clinical outcomes, patient-reported data and biosamples.

Xperiome is a global healthtech company that helps pharma get to know rare disease patients and their conditions faster by delivering deep insights into the patient experience. We have created Raremark as the place for the lived experience of rare disease. Raremark supports every stage of a patient’s health odyssey: a community to crowdsource wisdom, a library to catalog the lived experience, and a matching engine to find research opportunities. This data-driven knowledge bank of the rare experience allows us to match research-ready members to clinical and real-world studies, faster and smarter than ever before.

We are Pando. We’re on a mission to empower healthcare professionals to shape the future of care with AI-driven workflow automation and augmentation, offering intelligent support that enhances patient care and clinician well-being. Our secure communication platform is already trusted by 125,000+ users across hundreds of NHS hospitals and clinics in the UK and is rapidly expanding worldwide. This reach puts us in a unique position to deliver impactful, innovative services directly into the hands of healthcare teams everywhere.

Cisiv’s technology platform is fit-for-purpose and enables Pharmaceutical and Medical Device companies to collect and manage safety and efficacy studies in the real world. Through our technology, organizations are able to expand their global reach and provide access to more patients.   The platform, Baseline plus, spans every aspect of data collection and analysis as well as complex workflows for stakeholder engagement. This intuitive, modular web-based platform is highly configurable, providing unrivalled flexibility, no matter the scope or scale and has proven to reduce data management costs by 60%.   Baseline Plus is an industry leading platform, including EDC, eConsent, ePRO, eCOA, eDiary, Surveys, Safety, e-Source, with functionality suitable for site-based, decentralized, and hybrid research. Currently, Cisiv’s intelligent platform is utilized by 90% of the top global pharmaceutical companies and has supported 200+ projects with pharma and biotech organizations.

PeakData helps pharmaceutical companies learn more about their customers through our agile targeting and segmentation SaaS platform. PeakData is used by more than half of the top 20 Pharmaceuticals and engages 50+ staff in our offices in the USA, Germany, UK, Poland, Netherlands, and Switzerland.

Launched in the US in 2023, NuvoAir is a purpose-built, integrated specialty care platform that is reinventing the operating model through which care to complex cardiopulmonary patients is delivered. We emphasize the management of exacerbations, the key contributors to high healthcare costs and longitudinal care. Our platform empowers physicians, helping them maintain autonomy, deliver outstanding care and enhance their revenue in ways previously unattainable. By collaborating with health plans, risk-bearing entities, and innovative cardiologists and pulmonologists, we have redefined how patients with complex heart and lung issues, receive high quality care. To discover more about how NuvoAir is advancing high-value care in the cardiopulmonary space and to explore NuvoAirs extensive body of clinical evidence, visit nuvoair.com. Our recruiting email is talent@nuvoair.com, do not hesitate to reach out for any open position. Erin Murphree will be reaching out to you within short notice!

uMed combines RWE with the power of patient generated data to address the evidence gaps in life science research. By leveraging uMed’s ACCESS Research Platform which is embedded across a global network of healthcare institutions, researchers can rapidly access and engage with patients to generate insights derived from the decentralised collection of electronic health records, clinical outcomes, patient-reported data and biosamples.

Arecor Therapeutics plc is a globally focused biopharmaceutical company transforming patient care by bringing innovative medicines to market through the enhancement of existing therapeutic products. By applying our innovative proprietary formulation technology platform, Arestat™, we are developing an internal portfolio of proprietary products in diabetes and other indications, as well as working with leading pharmaceutical and biotechnology companies to deliver enhanced formulations of their therapeutic products. The Arestat™ platform is supported by an extensive patent portfolio.

Xperiome is a global healthtech company that helps pharma get to know rare disease patients and their conditions faster by delivering deep insights into the patient experience. We have created Raremark as the place for the lived experience of rare disease. Raremark supports every stage of a patient’s health odyssey: a community to crowdsource wisdom, a library to catalog the lived experience, and a matching engine to find research opportunities. This data-driven knowledge bank of the rare experience allows us to match research-ready members to clinical and real-world studies, faster and smarter than ever before.